TRPA1 and myocardial infarction: However, Lu et al. [37] reported that the administration of the TRPA1 agonist reduced the myocardial infarct size in myocardial IR, and the activation of the TRPA1 channel during reoxygenation in vitro decreased cardiomyocyte cell death and the release of lactate dehydrogenase.